Maternal serum alpha-fetoprotein screening activities of state health agencies : a survey

Maternal serum alpha-fetoprotein (MSAFP) screening has been demonstrated to be cost-effective on a population basis and is becoming standard practice. The American Society of Human Genetics has twice published policy statements to define the essential elements of a quality screening program. The pre...

Full description

Saved in:
Bibliographic Details
Published in:American journal of human genetics 1990-12, Vol.47 (6), p.899-903
Main Authors: CUNNINGHAM, G. C, KIZER, K. W
Format: Article
Language:English
Subjects:
alpha-Fetoproteins - analysis
Biological and medical sciences
Congenital Abnormalities - diagnosis
Female
Genetic Testing
Gynecology. Andrology. Obstetrics
Health Policy
Humans
Medical sciences
Pregnancy
Prenatal Diagnosis
Public Health Administration
screening
United States
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Maternal serum alpha-fetoprotein (MSAFP) screening has been demonstrated to be cost-effective on a population basis and is becoming standard practice. The American Society of Human Genetics has twice published policy statements to define the essential elements of a quality screening program. The present study reviewed the impact of these policy statements on state public-health agencies with respect to regulation or provision of MSAFP screening in their jurisdictions. With a few exceptions, states have not elected to play a major role in provision or regulation of this test. There is need to address issues of funding, standards, and data collection in a collaborative effort, if policy statements on genetic services are to be translated into effective state population screening.
ISSN:0002-9297
1537-6605